 Lisa Brenner
Concepts (521)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Veterans | 143 | 2025 | 1249 | 24.580 |
Why?
| | Suicide | 58 | 2025 | 508 | 13.580 |
Why?
| | Brain Injuries, Traumatic | 30 | 2024 | 303 | 10.490 |
Why?
| | Brain Injuries | 43 | 2024 | 461 | 9.170 |
Why?
| | Military Personnel | 38 | 2025 | 524 | 7.610 |
Why?
| | Stress Disorders, Post-Traumatic | 41 | 2025 | 758 | 7.270 |
Why?
| | Brain Concussion | 26 | 2024 | 476 | 6.610 |
Why?
| | Suicidal Ideation | 38 | 2025 | 401 | 6.080 |
Why?
| | United States Department of Veterans Affairs | 44 | 2025 | 561 | 5.900 |
Why?
| | Suicide, Attempted | 28 | 2025 | 317 | 4.890 |
Why?
| | United States | 113 | 2025 | 12186 | 3.790 |
Why?
| | Microbiota | 13 | 2024 | 647 | 3.710 |
Why?
| | Occupational Therapy | 4 | 2024 | 74 | 3.220 |
Why?
| | Post-Concussion Syndrome | 10 | 2024 | 154 | 3.100 |
Why?
| | Mental Health | 19 | 2025 | 562 | 3.090 |
Why?
| | Mental Disorders | 19 | 2024 | 893 | 3.030 |
Why?
| | Veterans Health | 13 | 2024 | 165 | 2.970 |
Why?
| | Humans | 251 | 2025 | 114698 | 2.700 |
Why?
| | Depressive Disorder, Major | 11 | 2024 | 301 | 2.460 |
Why?
| | Adult | 121 | 2025 | 30553 | 2.440 |
Why?
| | Blast Injuries | 8 | 2024 | 42 | 2.370 |
Why?
| | Middle Aged | 103 | 2025 | 26738 | 2.250 |
Why?
| | Iraq War, 2003-2011 | 19 | 2024 | 151 | 2.230 |
Why?
| | Male | 137 | 2025 | 55606 | 2.140 |
Why?
| | Female | 140 | 2025 | 59520 | 2.010 |
Why?
| | Gastrointestinal Microbiome | 7 | 2023 | 501 | 1.970 |
Why?
| | Self-Injurious Behavior | 6 | 2020 | 114 | 1.940 |
Why?
| | Toxoplasmosis | 7 | 2025 | 31 | 1.840 |
Why?
| | Toxoplasma | 6 | 2025 | 31 | 1.720 |
Why?
| | Sleep Initiation and Maintenance Disorders | 6 | 2024 | 119 | 1.650 |
Why?
| | Afghan Campaign 2001- | 16 | 2024 | 162 | 1.610 |
Why?
| | Psychological Trauma | 3 | 2022 | 54 | 1.550 |
Why?
| | Health Services Accessibility | 6 | 2024 | 763 | 1.520 |
Why?
| | Firearms | 9 | 2025 | 300 | 1.500 |
Why?
| | Health Personnel | 3 | 2021 | 574 | 1.450 |
Why?
| | Brain Injury, Chronic | 4 | 2016 | 21 | 1.400 |
Why?
| | Psychometrics | 11 | 2024 | 608 | 1.390 |
Why?
| | Qualitative Research | 12 | 2025 | 936 | 1.350 |
Why?
| | Surveys and Questionnaires | 22 | 2025 | 4624 | 1.320 |
Why?
| | Mental Health Services | 10 | 2024 | 317 | 1.320 |
Why?
| | Aged | 48 | 2024 | 19074 | 1.310 |
Why?
| | Sleep Wake Disorders | 5 | 2022 | 233 | 1.300 |
Why?
| | Feces | 4 | 2024 | 373 | 1.280 |
Why?
| | Young Adult | 44 | 2025 | 10471 | 1.260 |
Why?
| | Social Determinants of Health | 2 | 2023 | 137 | 1.250 |
Why?
| | Depressive Disorder | 5 | 2024 | 332 | 1.120 |
Why?
| | Cross-Sectional Studies | 23 | 2024 | 4410 | 1.050 |
Why?
| | Health Promotion | 5 | 2019 | 686 | 1.040 |
Why?
| | Hyperbaric Oxygenation | 3 | 2015 | 36 | 1.010 |
Why?
| | Pandemics | 5 | 2023 | 1320 | 1.010 |
Why?
| | RNA, Ribosomal, 16S | 4 | 2024 | 485 | 1.000 |
Why?
| | Violence | 5 | 2023 | 202 | 0.970 |
Why?
| | Aftercare | 3 | 2021 | 186 | 0.970 |
Why?
| | Risk Factors | 35 | 2025 | 8632 | 0.960 |
Why?
| | Severity of Illness Index | 14 | 2021 | 2540 | 0.940 |
Why?
| | DNA, Bacterial | 2 | 2024 | 311 | 0.860 |
Why?
| | Impulsive Behavior | 6 | 2024 | 113 | 0.850 |
Why?
| | Substance-Related Disorders | 5 | 2023 | 947 | 0.850 |
Why?
| | Transition to Adult Care | 1 | 2024 | 62 | 0.840 |
Why?
| | Retrospective Studies | 21 | 2024 | 12555 | 0.830 |
Why?
| | Longitudinal Studies | 15 | 2025 | 2387 | 0.830 |
Why?
| | Physical Therapy Specialty | 1 | 2023 | 34 | 0.820 |
Why?
| | Cerebral Palsy | 1 | 2024 | 80 | 0.810 |
Why?
| | Head Injuries, Closed | 1 | 2022 | 49 | 0.810 |
Why?
| | Evidence-Based Medicine | 3 | 2023 | 668 | 0.800 |
Why?
| | Mass Screening | 8 | 2024 | 1005 | 0.790 |
Why?
| | Patient Discharge | 5 | 2021 | 773 | 0.790 |
Why?
| | Drug Overdose | 2 | 2023 | 292 | 0.790 |
Why?
| | Inpatients | 5 | 2024 | 380 | 0.780 |
Why?
| | Cohort Studies | 16 | 2021 | 4895 | 0.780 |
Why?
| | Nutritional Status | 1 | 2024 | 287 | 0.770 |
Why?
| | Activities of Daily Living | 2 | 2024 | 349 | 0.770 |
Why?
| | Personality Assessment | 4 | 2017 | 77 | 0.760 |
Why?
| | Sequence Analysis, DNA | 1 | 2024 | 723 | 0.750 |
Why?
| | Occupational Diseases | 2 | 2020 | 128 | 0.750 |
Why?
| | Air Pollutants | 1 | 2024 | 242 | 0.730 |
Why?
| | Stroke Rehabilitation | 1 | 2021 | 34 | 0.720 |
Why?
| | Adaptation, Psychological | 7 | 2018 | 547 | 0.720 |
Why?
| | Spinal Cord Injuries | 2 | 2022 | 174 | 0.710 |
Why?
| | Risk Assessment | 17 | 2025 | 2968 | 0.710 |
Why?
| | Neuropsychological Tests | 9 | 2024 | 927 | 0.690 |
Why?
| | Models, Psychological | 1 | 2022 | 297 | 0.690 |
Why?
| | Dysbiosis | 2 | 2018 | 146 | 0.680 |
Why?
| | Disability Evaluation | 6 | 2019 | 271 | 0.680 |
Why?
| | Antidepressive Agents | 5 | 2024 | 195 | 0.670 |
Why?
| | Adolescent | 21 | 2025 | 17853 | 0.640 |
Why?
| | Psychotherapy | 2 | 2017 | 149 | 0.640 |
Why?
| | Patient Readmission | 1 | 2024 | 610 | 0.630 |
Why?
| | Healthcare Disparities | 1 | 2024 | 480 | 0.630 |
Why?
| | Safety | 2 | 2020 | 298 | 0.620 |
Why?
| | Animal Assisted Therapy | 1 | 2018 | 9 | 0.620 |
Why?
| | Pets | 1 | 2018 | 20 | 0.620 |
Why?
| | Child Development | 1 | 2022 | 385 | 0.610 |
Why?
| | Wounds, Gunshot | 5 | 2023 | 193 | 0.610 |
Why?
| | Antibodies, Protozoan | 5 | 2025 | 30 | 0.610 |
Why?
| | Death Certificates | 2 | 2023 | 30 | 0.610 |
Why?
| | Mobile Applications | 1 | 2020 | 141 | 0.610 |
Why?
| | Parkinson Disease | 1 | 2022 | 345 | 0.600 |
Why?
| | Hope | 1 | 2018 | 13 | 0.600 |
Why?
| | Sense of Coherence | 1 | 2018 | 13 | 0.600 |
Why?
| | Patient Acceptance of Health Care | 4 | 2024 | 681 | 0.590 |
Why?
| | Triage | 1 | 2020 | 199 | 0.590 |
Why?
| | Hospitals, Veterans | 7 | 2022 | 244 | 0.580 |
Why?
| | Child Abuse | 1 | 2022 | 456 | 0.580 |
Why?
| | Caregivers | 1 | 2024 | 717 | 0.570 |
Why?
| | Risk | 5 | 2023 | 812 | 0.570 |
Why?
| | Inflammation | 7 | 2022 | 2480 | 0.560 |
Why?
| | Drug Packaging | 1 | 2017 | 42 | 0.560 |
Why?
| | Psychotherapy, Group | 1 | 2017 | 61 | 0.550 |
Why?
| | Executive Function | 4 | 2017 | 380 | 0.550 |
Why?
| | Probiotics | 1 | 2017 | 46 | 0.550 |
Why?
| | Sleep Apnea, Obstructive | 3 | 2024 | 196 | 0.550 |
Why?
| | Cognition Disorders | 3 | 2014 | 476 | 0.550 |
Why?
| | Patient Care Team | 3 | 2024 | 517 | 0.550 |
Why?
| | Hospitalization | 5 | 2019 | 1752 | 0.530 |
Why?
| | Home Care Services | 1 | 2019 | 223 | 0.530 |
Why?
| | Outpatients | 2 | 2023 | 326 | 0.530 |
Why?
| | Protective Factors | 2 | 2015 | 87 | 0.530 |
Why?
| | Multiple Trauma | 2 | 2024 | 96 | 0.530 |
Why?
| | Problem Solving | 1 | 2017 | 141 | 0.530 |
Why?
| | Feasibility Studies | 5 | 2021 | 740 | 0.530 |
Why?
| | Postural Balance | 1 | 2018 | 183 | 0.530 |
Why?
| | Cause of Death | 2 | 2023 | 361 | 0.510 |
Why?
| | Headache | 3 | 2022 | 133 | 0.510 |
Why?
| | Depression | 5 | 2025 | 1134 | 0.500 |
Why?
| | Reproducibility of Results | 10 | 2024 | 2765 | 0.490 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 338 | 0.490 |
Why?
| | Coronavirus Infections | 1 | 2020 | 330 | 0.490 |
Why?
| | Quality Improvement | 2 | 2020 | 950 | 0.470 |
Why?
| | Self Report | 5 | 2017 | 696 | 0.470 |
Why?
| | Hypertension | 1 | 2022 | 1056 | 0.460 |
Why?
| | Combat Disorders | 2 | 2017 | 33 | 0.460 |
Why?
| | Case-Control Studies | 8 | 2022 | 3003 | 0.460 |
Why?
| | Afghanistan | 3 | 2024 | 108 | 0.460 |
Why?
| | Comorbidity | 9 | 2022 | 1448 | 0.460 |
Why?
| | Disabled Persons | 2 | 2012 | 134 | 0.450 |
Why?
| | Recovery of Function | 5 | 2024 | 574 | 0.440 |
Why?
| | Neuropsychology | 2 | 2011 | 32 | 0.430 |
Why?
| | Emotions | 1 | 2018 | 472 | 0.430 |
Why?
| | Health Planning | 1 | 2013 | 46 | 0.430 |
Why?
| | Athletic Injuries | 1 | 2019 | 456 | 0.430 |
Why?
| | Social Support | 5 | 2024 | 528 | 0.420 |
Why?
| | Anxiety Disorders | 1 | 2016 | 303 | 0.420 |
Why?
| | Risk Management | 1 | 2014 | 89 | 0.420 |
Why?
| | Iraq | 2 | 2024 | 81 | 0.420 |
Why?
| | Medication Adherence | 1 | 2017 | 536 | 0.410 |
Why?
| | Quality of Life | 5 | 2019 | 2353 | 0.410 |
Why?
| | Observational Studies as Topic | 2 | 2024 | 90 | 0.410 |
Why?
| | Trauma Severity Indices | 5 | 2019 | 114 | 0.400 |
Why?
| | Interpersonal Relations | 1 | 2015 | 341 | 0.400 |
Why?
| | Stress, Physiological | 1 | 2015 | 378 | 0.400 |
Why?
| | Telemedicine | 1 | 2020 | 662 | 0.400 |
Why?
| | Psychiatric Status Rating Scales | 6 | 2018 | 482 | 0.400 |
Why?
| | Attitude of Health Personnel | 2 | 2016 | 975 | 0.400 |
Why?
| | Aged, 80 and over | 7 | 2021 | 6347 | 0.390 |
Why?
| | Colorado | 6 | 2024 | 4100 | 0.390 |
Why?
| | Ambulatory Care | 3 | 2018 | 478 | 0.380 |
Why?
| | Prevalence | 9 | 2024 | 2251 | 0.370 |
Why?
| | Porphyromonas gingivalis | 2 | 2022 | 17 | 0.370 |
Why?
| | Ethanol | 3 | 2024 | 538 | 0.360 |
Why?
| | Socioeconomic Factors | 6 | 2023 | 1079 | 0.360 |
Why?
| | Bayes Theorem | 2 | 2022 | 329 | 0.360 |
Why?
| | Post-Traumatic Headache | 2 | 2020 | 3 | 0.360 |
Why?
| | Wounds and Injuries | 1 | 2018 | 749 | 0.350 |
Why?
| | Sex Offenses | 2 | 2023 | 148 | 0.350 |
Why?
| | Tryptophan | 3 | 2022 | 136 | 0.340 |
Why?
| | Terminology as Topic | 1 | 2011 | 187 | 0.340 |
Why?
| | United States Department of Defense | 2 | 2025 | 16 | 0.330 |
Why?
| | Diagnostic Imaging | 2 | 2011 | 275 | 0.320 |
Why?
| | Public Health | 5 | 2022 | 434 | 0.320 |
Why?
| | Sleep | 3 | 2024 | 632 | 0.320 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2024 | 1214 | 0.320 |
Why?
| | Crisis Intervention | 3 | 2024 | 29 | 0.320 |
Why?
| | Quality of Health Care | 1 | 2013 | 573 | 0.320 |
Why?
| | Cognitive Dysfunction | 1 | 2013 | 284 | 0.310 |
Why?
| | Stress, Psychological | 2 | 2020 | 944 | 0.310 |
Why?
| | Dizziness | 2 | 2019 | 70 | 0.310 |
Why?
| | Housing | 2 | 2020 | 114 | 0.310 |
Why?
| | Amish | 2 | 2019 | 7 | 0.310 |
Why?
| | Program Evaluation | 3 | 2024 | 822 | 0.310 |
Why?
| | Intention | 1 | 2009 | 144 | 0.300 |
Why?
| | Immunoglobulin G | 5 | 2024 | 770 | 0.300 |
Why?
| | Kynurenine | 3 | 2018 | 81 | 0.290 |
Why?
| | Age Factors | 6 | 2024 | 2894 | 0.290 |
Why?
| | Neuropsychiatry | 2 | 2020 | 15 | 0.280 |
Why?
| | Health Behavior | 1 | 2012 | 704 | 0.280 |
Why?
| | Emergency Service, Hospital | 6 | 2020 | 1820 | 0.280 |
Why?
| | Follow-Up Studies | 5 | 2022 | 4411 | 0.270 |
Why?
| | Emergency Medical Services | 2 | 2023 | 590 | 0.270 |
Why?
| | Treatment Outcome | 10 | 2022 | 9088 | 0.270 |
Why?
| | Time Factors | 6 | 2019 | 6116 | 0.260 |
Why?
| | Environment, Controlled | 2 | 2016 | 19 | 0.260 |
Why?
| | Factor Analysis, Statistical | 4 | 2024 | 257 | 0.260 |
Why?
| | Hotlines | 4 | 2024 | 29 | 0.260 |
Why?
| | Machine Learning | 3 | 2025 | 316 | 0.250 |
Why?
| | Motivation | 1 | 2009 | 494 | 0.250 |
Why?
| | Prospective Studies | 9 | 2022 | 6220 | 0.250 |
Why?
| | Rehabilitation Centers | 2 | 2024 | 32 | 0.250 |
Why?
| | Affect | 2 | 2018 | 246 | 0.240 |
Why?
| | Anxiety | 4 | 2025 | 840 | 0.240 |
Why?
| | Logistic Models | 7 | 2025 | 1841 | 0.240 |
Why?
| | Delay Discounting | 1 | 2024 | 16 | 0.240 |
Why?
| | Complementary Therapies | 2 | 2016 | 72 | 0.240 |
Why?
| | Prognosis | 3 | 2024 | 3329 | 0.230 |
Why?
| | Sensitivity and Specificity | 4 | 2013 | 1693 | 0.230 |
Why?
| | Policy | 2 | 2022 | 137 | 0.230 |
Why?
| | Lomustine | 1 | 2024 | 14 | 0.230 |
Why?
| | Patient Health Questionnaire | 1 | 2024 | 21 | 0.230 |
Why?
| | Mouth | 1 | 2024 | 70 | 0.230 |
Why?
| | Natural Language Processing | 1 | 2025 | 72 | 0.230 |
Why?
| | Metals, Heavy | 1 | 2024 | 19 | 0.220 |
Why?
| | Wildfires | 1 | 2024 | 18 | 0.220 |
Why?
| | Sex Distribution | 2 | 2023 | 337 | 0.220 |
Why?
| | Pesticides | 1 | 2024 | 49 | 0.220 |
Why?
| | Irritable Bowel Syndrome | 1 | 2023 | 29 | 0.220 |
Why?
| | Clinical Protocols | 2 | 2015 | 233 | 0.220 |
Why?
| | Global Burden of Disease | 1 | 2023 | 15 | 0.210 |
Why?
| | Transportation of Patients | 1 | 2023 | 52 | 0.210 |
Why?
| | Prednisone | 1 | 2024 | 229 | 0.210 |
Why?
| | Psychiatric Department, Hospital | 2 | 2014 | 13 | 0.210 |
Why?
| | Disaster Planning | 1 | 2024 | 74 | 0.210 |
Why?
| | Abruptio Placentae | 1 | 2022 | 3 | 0.210 |
Why?
| | Disasters | 1 | 2024 | 88 | 0.210 |
Why?
| | Interview, Psychological | 2 | 2015 | 86 | 0.200 |
Why?
| | Aggression | 4 | 2021 | 183 | 0.200 |
Why?
| | Incidence | 6 | 2019 | 2313 | 0.200 |
Why?
| | Ohio | 1 | 2022 | 135 | 0.200 |
Why?
| | Pharmacogenomic Testing | 1 | 2022 | 53 | 0.200 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2024 | 1183 | 0.200 |
Why?
| | Pilot Projects | 5 | 2024 | 1373 | 0.190 |
Why?
| | Schizophrenia | 2 | 2016 | 414 | 0.190 |
Why?
| | Inappropriate Prescribing | 1 | 2022 | 52 | 0.190 |
Why?
| | Air Pollution | 1 | 2024 | 169 | 0.190 |
Why?
| | Meta-Analysis as Topic | 1 | 2022 | 158 | 0.190 |
Why?
| | Neopterin | 2 | 2022 | 9 | 0.190 |
Why?
| | HIV Infections | 1 | 2015 | 2469 | 0.190 |
Why?
| | Frailty | 1 | 2024 | 115 | 0.190 |
Why?
| | Subacute Care | 1 | 2022 | 71 | 0.190 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2024 | 439 | 0.190 |
Why?
| | Skin | 2 | 2023 | 655 | 0.190 |
Why?
| | Parenting | 1 | 2024 | 252 | 0.190 |
Why?
| | Cost of Illness | 1 | 2023 | 254 | 0.180 |
Why?
| | Hepatic Encephalopathy | 1 | 2021 | 19 | 0.180 |
Why?
| | Drug Interactions | 1 | 2022 | 338 | 0.180 |
Why?
| | Skilled Nursing Facilities | 1 | 2022 | 121 | 0.180 |
Why?
| | Bacteria | 2 | 2024 | 725 | 0.180 |
Why?
| | Environmental Exposure | 1 | 2024 | 372 | 0.180 |
Why?
| | Anger | 3 | 2021 | 55 | 0.180 |
Why?
| | Sex Factors | 6 | 2024 | 1715 | 0.170 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2021 | 60 | 0.170 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 4 | 2016 | 230 | 0.170 |
Why?
| | Communicable Diseases | 1 | 2022 | 129 | 0.170 |
Why?
| | Seasonal Affective Disorder | 1 | 2020 | 9 | 0.170 |
Why?
| | Photophobia | 1 | 2019 | 10 | 0.170 |
Why?
| | Hyperacusis | 1 | 2019 | 9 | 0.170 |
Why?
| | Receptors, Calcitriol | 1 | 2020 | 53 | 0.170 |
Why?
| | Survival Analysis | 3 | 2011 | 1211 | 0.170 |
Why?
| | Vitamin D Deficiency | 1 | 2021 | 158 | 0.170 |
Why?
| | Hypesthesia | 1 | 2019 | 16 | 0.170 |
Why?
| | Health Services Needs and Demand | 1 | 2021 | 243 | 0.170 |
Why?
| | Morals | 1 | 2020 | 65 | 0.170 |
Why?
| | Environment Design | 2 | 2016 | 24 | 0.170 |
Why?
| | Periodontitis | 1 | 2020 | 42 | 0.170 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2023 | 284 | 0.170 |
Why?
| | Alcoholism | 2 | 2024 | 713 | 0.160 |
Why?
| | Paresis | 1 | 2019 | 28 | 0.160 |
Why?
| | Arm Injuries | 1 | 2019 | 23 | 0.160 |
Why?
| | Premature Birth | 1 | 2022 | 276 | 0.160 |
Why?
| | Chronic Traumatic Encephalopathy | 1 | 2019 | 14 | 0.160 |
Why?
| | Odds Ratio | 5 | 2016 | 953 | 0.160 |
Why?
| | Delirium | 2 | 2011 | 66 | 0.160 |
Why?
| | Liver Cirrhosis | 1 | 2021 | 227 | 0.160 |
Why?
| | Diet | 2 | 2023 | 1080 | 0.160 |
Why?
| | Fatigue | 2 | 2018 | 294 | 0.160 |
Why?
| | Patient-Centered Care | 1 | 2024 | 473 | 0.160 |
Why?
| | Child | 5 | 2024 | 18420 | 0.160 |
Why?
| | Cross-Over Studies | 2 | 2018 | 440 | 0.160 |
Why?
| | Medical Staff, Hospital | 1 | 2019 | 75 | 0.160 |
Why?
| | Environmental Microbiology | 1 | 2019 | 43 | 0.160 |
Why?
| | Occupational Injuries | 1 | 2019 | 46 | 0.160 |
Why?
| | Women's Health | 1 | 2021 | 271 | 0.160 |
Why?
| | Arm | 1 | 2019 | 104 | 0.150 |
Why?
| | Psychotherapy, Brief | 1 | 2018 | 28 | 0.150 |
Why?
| | Reproductive Health | 3 | 2024 | 71 | 0.150 |
Why?
| | Food Supply | 1 | 2019 | 64 | 0.150 |
Why?
| | Adiponectin | 1 | 2020 | 213 | 0.150 |
Why?
| | Electronic Health Records | 1 | 2025 | 800 | 0.150 |
Why?
| | Health Services Research | 1 | 2021 | 371 | 0.150 |
Why?
| | Phenylalanine | 1 | 2018 | 57 | 0.150 |
Why?
| | Dogs | 1 | 2018 | 334 | 0.140 |
Why?
| | Disease Models, Animal | 2 | 2017 | 3535 | 0.140 |
Why?
| | Prefrontal Cortex | 2 | 2017 | 262 | 0.140 |
Why?
| | Tyrosine | 1 | 2018 | 214 | 0.140 |
Why?
| | Databases, Factual | 1 | 2022 | 1125 | 0.140 |
Why?
| | Prebiotics | 1 | 2017 | 23 | 0.140 |
Why?
| | Confidence Intervals | 3 | 2016 | 305 | 0.140 |
Why?
| | Gliadin | 1 | 2016 | 12 | 0.140 |
Why?
| | Rural Population | 1 | 2020 | 446 | 0.140 |
Why?
| | Decision Making | 3 | 2024 | 782 | 0.140 |
Why?
| | Patient Selection | 1 | 2020 | 641 | 0.140 |
Why?
| | Obesity | 2 | 2019 | 2508 | 0.140 |
Why?
| | Amygdala | 2 | 2017 | 170 | 0.130 |
Why?
| | Physical Therapy Modalities | 1 | 2019 | 265 | 0.130 |
Why?
| | Nervous System Diseases | 1 | 2019 | 256 | 0.130 |
Why?
| | Housing, Animal | 1 | 2016 | 42 | 0.130 |
Why?
| | Perception | 2 | 2019 | 311 | 0.130 |
Why?
| | Social Work, Psychiatric | 1 | 2015 | 3 | 0.130 |
Why?
| | Neuroimaging | 2 | 2017 | 249 | 0.130 |
Why?
| | Immunomodulation | 1 | 2016 | 84 | 0.130 |
Why?
| | Analgesics, Opioid | 1 | 2023 | 771 | 0.130 |
Why?
| | Community Mental Health Centers | 1 | 2015 | 13 | 0.130 |
Why?
| | Actigraphy | 1 | 2016 | 75 | 0.130 |
Why?
| | Counseling | 2 | 2023 | 342 | 0.120 |
Why?
| | Medical Records | 1 | 2016 | 153 | 0.120 |
Why?
| | Prescription Drug Misuse | 1 | 2015 | 38 | 0.120 |
Why?
| | Delivery of Health Care | 4 | 2023 | 833 | 0.120 |
Why?
| | Burnout, Professional | 1 | 2020 | 322 | 0.120 |
Why?
| | Israel | 2 | 2025 | 40 | 0.120 |
Why?
| | Health Status Indicators | 2 | 2012 | 156 | 0.120 |
Why?
| | Thalamus | 1 | 2015 | 74 | 0.120 |
Why?
| | Propylamines | 1 | 2014 | 11 | 0.120 |
Why?
| | Adrenergic Uptake Inhibitors | 1 | 2014 | 13 | 0.120 |
Why?
| | Biomedical Research | 1 | 2020 | 585 | 0.120 |
Why?
| | Mood Disorders | 1 | 2015 | 112 | 0.120 |
Why?
| | Forecasting | 1 | 2016 | 330 | 0.110 |
Why?
| | Analgesics | 1 | 2015 | 158 | 0.110 |
Why?
| | Cross-Cultural Comparison | 1 | 2014 | 77 | 0.110 |
Why?
| | Interviews as Topic | 4 | 2018 | 583 | 0.110 |
Why?
| | Cerebellum | 1 | 2015 | 200 | 0.110 |
Why?
| | Self Concept | 1 | 2015 | 214 | 0.110 |
Why?
| | Percutaneous Coronary Intervention | 1 | 2019 | 444 | 0.110 |
Why?
| | Australia | 1 | 2014 | 206 | 0.110 |
Why?
| | Forensic Psychiatry | 1 | 2013 | 25 | 0.110 |
Why?
| | Patient Satisfaction | 1 | 2017 | 578 | 0.110 |
Why?
| | Employment | 1 | 2014 | 137 | 0.110 |
Why?
| | Seroepidemiologic Studies | 3 | 2019 | 138 | 0.110 |
Why?
| | Chi-Square Distribution | 2 | 2011 | 493 | 0.110 |
Why?
| | Hawaii | 2 | 2024 | 38 | 0.110 |
Why?
| | Ownership | 2 | 2025 | 82 | 0.110 |
Why?
| | Coronary Artery Disease | 1 | 2019 | 607 | 0.110 |
Why?
| | Infant | 2 | 2022 | 7964 | 0.100 |
Why?
| | Linear Models | 3 | 2010 | 768 | 0.100 |
Why?
| | Stress Disorders, Traumatic | 1 | 2013 | 23 | 0.100 |
Why?
| | Sex | 1 | 2012 | 3 | 0.100 |
Why?
| | Multivariate Analysis | 2 | 2019 | 1430 | 0.100 |
Why?
| | Social Stigma | 1 | 2013 | 87 | 0.100 |
Why?
| | Football | 1 | 2013 | 76 | 0.100 |
Why?
| | Algorithms | 3 | 2019 | 1470 | 0.100 |
Why?
| | Advisory Committees | 1 | 2013 | 208 | 0.100 |
Why?
| | Computer Communication Networks | 1 | 2012 | 32 | 0.100 |
Why?
| | Task Performance and Analysis | 2 | 2017 | 159 | 0.100 |
Why?
| | Walking | 1 | 2015 | 422 | 0.100 |
Why?
| | Information Dissemination | 1 | 2013 | 186 | 0.100 |
Why?
| | Statistics, Nonparametric | 2 | 2009 | 385 | 0.090 |
Why?
| | Therapy, Computer-Assisted | 1 | 2012 | 58 | 0.090 |
Why?
| | Interprofessional Relations | 1 | 2013 | 249 | 0.090 |
Why?
| | Consciousness Disorders | 1 | 2011 | 19 | 0.090 |
Why?
| | Ethics, Professional | 1 | 2011 | 14 | 0.090 |
Why?
| | Brain | 3 | 2021 | 2371 | 0.090 |
Why?
| | Predictive Value of Tests | 2 | 2019 | 1796 | 0.090 |
Why?
| | Life Change Events | 1 | 2012 | 135 | 0.090 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2011 | 83 | 0.090 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 364 | 0.090 |
Why?
| | Multiple Sclerosis | 1 | 2015 | 376 | 0.090 |
Why?
| | Glucose | 1 | 2015 | 897 | 0.090 |
Why?
| | Psychomotor Agitation | 1 | 2011 | 65 | 0.090 |
Why?
| | Health Policy | 1 | 2013 | 334 | 0.090 |
Why?
| | Inservice Training | 1 | 2011 | 105 | 0.090 |
Why?
| | Research | 1 | 2013 | 394 | 0.090 |
Why?
| | Life Style | 1 | 2012 | 430 | 0.090 |
Why?
| | Health Plan Implementation | 1 | 2011 | 132 | 0.090 |
Why?
| | HIV-1 | 1 | 2015 | 768 | 0.090 |
Why?
| | Interdisciplinary Communication | 1 | 2011 | 183 | 0.090 |
Why?
| | Elective Surgical Procedures | 1 | 2011 | 151 | 0.080 |
Why?
| | Diagnosis, Differential | 1 | 2014 | 1342 | 0.080 |
Why?
| | Irritable Mood | 2 | 2021 | 48 | 0.080 |
Why?
| | Analysis of Variance | 2 | 2011 | 1226 | 0.080 |
Why?
| | Religion and Psychology | 1 | 2009 | 24 | 0.080 |
Why?
| | Explosions | 1 | 2009 | 11 | 0.080 |
Why?
| | Patient Education as Topic | 1 | 2014 | 680 | 0.080 |
Why?
| | Affective Symptoms | 1 | 2009 | 47 | 0.080 |
Why?
| | Data Collection | 1 | 2012 | 620 | 0.080 |
Why?
| | Alcohol Drinking | 1 | 2014 | 651 | 0.080 |
Why?
| | Neurologic Examination | 1 | 2009 | 114 | 0.080 |
Why?
| | Cooperative Behavior | 1 | 2011 | 381 | 0.080 |
Why?
| | Hypogonadism | 1 | 2009 | 75 | 0.080 |
Why?
| | Proportional Hazards Models | 1 | 2011 | 1075 | 0.080 |
Why?
| | Population Surveillance | 1 | 2011 | 392 | 0.080 |
Why?
| | Resilience, Psychological | 1 | 2009 | 96 | 0.080 |
Why?
| | Needs Assessment | 1 | 2009 | 314 | 0.070 |
Why?
| | Decision Support Techniques | 1 | 2011 | 355 | 0.070 |
Why?
| | Brain Mapping | 1 | 2011 | 524 | 0.070 |
Why?
| | Pregnancy | 3 | 2024 | 5520 | 0.070 |
Why?
| | Aging | 1 | 2017 | 1618 | 0.070 |
Why?
| | Glasgow Coma Scale | 3 | 2014 | 153 | 0.070 |
Why?
| | Language Disorders | 1 | 2007 | 32 | 0.070 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2019 | 797 | 0.070 |
Why?
| | Animals | 5 | 2018 | 31708 | 0.070 |
Why?
| | Psychological Tests | 1 | 2007 | 120 | 0.070 |
Why?
| | Healthy Volunteers | 2 | 2018 | 197 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 2 | 2024 | 3053 | 0.060 |
Why?
| | Testosterone | 1 | 2009 | 343 | 0.060 |
Why?
| | Length of Stay | 1 | 2009 | 962 | 0.060 |
Why?
| | Armed Conflicts | 1 | 2025 | 14 | 0.060 |
Why?
| | Drug Storage | 1 | 2025 | 58 | 0.060 |
Why?
| | Terrorism | 1 | 2024 | 26 | 0.060 |
Why?
| | Reproductive Health Services | 1 | 2024 | 10 | 0.060 |
Why?
| | Cognition | 2 | 2022 | 989 | 0.060 |
Why?
| | Transcranial Magnetic Stimulation | 1 | 2024 | 44 | 0.060 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 1355 | 0.060 |
Why?
| | Diffusion Tensor Imaging | 1 | 2024 | 63 | 0.060 |
Why?
| | Social Change | 1 | 2024 | 13 | 0.060 |
Why?
| | Warfare | 1 | 2025 | 75 | 0.060 |
Why?
| | Treatment Adherence and Compliance | 1 | 2024 | 18 | 0.060 |
Why?
| | Video Recording | 1 | 2024 | 143 | 0.060 |
Why?
| | Biomarkers | 2 | 2024 | 3408 | 0.060 |
Why?
| | Frontal Lobe | 1 | 2024 | 141 | 0.060 |
Why?
| | Asphyxia | 1 | 2023 | 21 | 0.060 |
Why?
| | Fertility | 1 | 2024 | 130 | 0.050 |
Why?
| | Friends | 1 | 2023 | 46 | 0.050 |
Why?
| | Guam | 1 | 2023 | 7 | 0.050 |
Why?
| | Choice Behavior | 1 | 2024 | 155 | 0.050 |
Why?
| | Immunoglobulin M | 1 | 2024 | 246 | 0.050 |
Why?
| | Stillbirth | 1 | 2022 | 57 | 0.050 |
Why?
| | Postoperative Complications | 2 | 2011 | 2128 | 0.050 |
Why?
| | Public Opinion | 1 | 2022 | 59 | 0.050 |
Why?
| | Remission Induction | 1 | 2022 | 233 | 0.050 |
Why?
| | Pregnancy Trimester, First | 1 | 2022 | 125 | 0.050 |
Why?
| | Social Justice | 1 | 2022 | 67 | 0.050 |
Why?
| | Disease Susceptibility | 1 | 2023 | 316 | 0.050 |
Why?
| | Pharmacogenetics | 1 | 2022 | 149 | 0.050 |
Why?
| | Breast Neoplasms | 1 | 2012 | 1862 | 0.050 |
Why?
| | Nursing Homes | 1 | 2022 | 138 | 0.050 |
Why?
| | Double-Blind Method | 2 | 2015 | 1660 | 0.040 |
Why?
| | Research Report | 1 | 2021 | 75 | 0.040 |
Why?
| | Internet | 1 | 2024 | 596 | 0.040 |
Why?
| | Cathelicidins | 1 | 2020 | 38 | 0.040 |
Why?
| | Patient Compliance | 1 | 2024 | 525 | 0.040 |
Why?
| | Clinical Decision-Making | 1 | 2022 | 268 | 0.040 |
Why?
| | Lithium Compounds | 1 | 2019 | 9 | 0.040 |
Why?
| | Central Nervous System | 1 | 2021 | 235 | 0.040 |
Why?
| | Disease Progression | 2 | 2017 | 2380 | 0.040 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2020 | 75 | 0.040 |
Why?
| | September 11 Terrorist Attacks | 1 | 2019 | 22 | 0.040 |
Why?
| | Research Design | 2 | 2015 | 928 | 0.040 |
Why?
| | Retirement | 1 | 2019 | 25 | 0.040 |
Why?
| | Wakefulness | 1 | 2019 | 128 | 0.040 |
Why?
| | Patient Preference | 1 | 2020 | 167 | 0.040 |
Why?
| | Ketamine | 1 | 2019 | 92 | 0.040 |
Why?
| | Attitude | 1 | 2020 | 229 | 0.040 |
Why?
| | Serologic Tests | 1 | 2018 | 49 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 520 | 0.040 |
Why?
| | Germany | 1 | 2018 | 84 | 0.040 |
Why?
| | Memory Disorders | 1 | 2019 | 155 | 0.040 |
Why?
| | Nutrition Surveys | 1 | 2019 | 224 | 0.040 |
Why?
| | Referral and Consultation | 1 | 2022 | 635 | 0.040 |
Why?
| | Seasons | 1 | 2020 | 442 | 0.040 |
Why?
| | Behavior Therapy | 1 | 2019 | 226 | 0.030 |
Why?
| | Placenta | 1 | 2022 | 628 | 0.030 |
Why?
| | RNA, Bacterial | 1 | 2017 | 174 | 0.030 |
Why?
| | Behavioral Risk Factor Surveillance System | 1 | 2016 | 44 | 0.030 |
Why?
| | Organ Size | 1 | 2017 | 436 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2019 | 1121 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2018 | 470 | 0.030 |
Why?
| | War-Related Injuries | 1 | 2017 | 33 | 0.030 |
Why?
| | Sick Building Syndrome | 1 | 2015 | 4 | 0.030 |
Why?
| | Dopamine | 1 | 2018 | 236 | 0.030 |
Why?
| | Poverty | 1 | 2019 | 442 | 0.030 |
Why?
| | Reward | 1 | 2017 | 211 | 0.030 |
Why?
| | Psychological Techniques | 1 | 2014 | 7 | 0.030 |
Why?
| | Environment | 1 | 2017 | 332 | 0.030 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2015 | 113 | 0.030 |
Why?
| | Radiopharmaceuticals | 1 | 2015 | 157 | 0.030 |
Why?
| | Gene Expression | 1 | 2020 | 1421 | 0.030 |
Why?
| | Atomoxetine Hydrochloride | 1 | 2014 | 4 | 0.030 |
Why?
| | Community Mental Health Services | 1 | 2015 | 84 | 0.030 |
Why?
| | Florida | 1 | 2014 | 73 | 0.030 |
Why?
| | Body Weight | 1 | 2019 | 869 | 0.030 |
Why?
| | Risk-Taking | 1 | 2017 | 333 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2015 | 259 | 0.030 |
Why?
| | Health Surveys | 1 | 2015 | 443 | 0.030 |
Why?
| | Focus Groups | 1 | 2015 | 383 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2019 | 1177 | 0.030 |
Why?
| | Personality | 1 | 2014 | 113 | 0.030 |
Why?
| | Exercise Test | 1 | 2015 | 544 | 0.030 |
Why?
| | Pain Measurement | 1 | 2015 | 444 | 0.030 |
Why?
| | Suramin | 1 | 2012 | 6 | 0.030 |
Why?
| | Leukopenia | 1 | 2012 | 27 | 0.030 |
Why?
| | Phenotype | 1 | 2020 | 2796 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2022 | 5047 | 0.020 |
Why?
| | Taxoids | 1 | 2012 | 93 | 0.020 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2012 | 83 | 0.020 |
Why?
| | Health Priorities | 1 | 2012 | 34 | 0.020 |
Why?
| | Nausea | 1 | 2012 | 101 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2012 | 292 | 0.020 |
Why?
| | Paclitaxel | 1 | 2012 | 190 | 0.020 |
Why?
| | Ethical Review | 1 | 2011 | 3 | 0.020 |
Why?
| | Wheelchairs | 1 | 2011 | 16 | 0.020 |
Why?
| | Dementia | 1 | 2013 | 187 | 0.020 |
Why?
| | Personal Satisfaction | 1 | 2012 | 182 | 0.020 |
Why?
| | Personal Autonomy | 1 | 2011 | 39 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2012 | 620 | 0.020 |
Why?
| | Age Distribution | 1 | 2011 | 342 | 0.020 |
Why?
| | Medical History Taking | 1 | 2010 | 114 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2012 | 718 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2012 | 523 | 0.020 |
Why?
| | Reference Values | 1 | 2011 | 743 | 0.020 |
Why?
| | Geriatric Assessment | 1 | 2011 | 176 | 0.020 |
Why?
| | Pain | 1 | 2015 | 705 | 0.020 |
Why?
| | False Negative Reactions | 1 | 2009 | 48 | 0.020 |
Why?
| | Injury Severity Score | 1 | 2011 | 499 | 0.020 |
Why?
| | Self Efficacy | 1 | 2012 | 355 | 0.020 |
Why?
| | False Positive Reactions | 1 | 2009 | 109 | 0.020 |
Why?
| | Preoperative Care | 1 | 2011 | 319 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 1842 | 0.020 |
Why?
| | ROC Curve | 1 | 2009 | 442 | 0.020 |
Why?
| | Health Status | 1 | 2012 | 722 | 0.020 |
Why?
| | Survival Rate | 1 | 2011 | 1644 | 0.020 |
Why?
| | Physician-Patient Relations | 1 | 2011 | 462 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2013 | 1395 | 0.020 |
Why?
| | Mice | 1 | 2016 | 14871 | 0.010 |
Why?
|
|
Brenner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|